VIGL Vigil Neuroscience
- 1.580
- -0.120-7.06%
- 1.560
- -0.020-1.27%
Vigil Neuroscience News
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Budd Haeberlein Samantha L.
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.6%),Citadel Advisors Holdings LP(3.6%), etc.
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(3.92%),Deep Track Biotechnology Master Fund, Ltd.(3.92%), etc.
Vigil Neuroscience | 10-Q: Q3 2024 Earnings Report
Vigil Neuroscience | 8-K: Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vida Ventures GP III, L.L.C.(12.7%),Stefan Vitorovic(12.7%), etc.
Vigil Neuroscience | 144: Notice of proposed sale of securities pursuant to Rule 144
Vigil Neuroscience | 8-K: Current report
Vigil Neuroscience | 10-Q: Q2 2024 Earnings Report
Vigil Neuroscience | 8-K: Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience | SC 13G: Statement of acquisition of beneficial ownership by individuals-Raymond Debbane(5.3%),Invus Public Equities, L.P.(4.9%), etc.
Vigil Neuroscience | 8-K: Current report
Vigil Neuroscience | 8-K: Current report
Vigil Neuroscience | 8-K: Current report
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Blanchard Cheryl R
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Budd Haeberlein Samantha L.
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce
No Data